series-b
Stage
1
Investors
About
Capstan Therapeutics is a biotechnology company developing in vivo cell engineering therapeutics. They use targeted lipid nanoparticles to deliver mRNA payloads to specific cell types for treating various diseases.
Explore Capstan Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.